A new, non-invasive technology that improves the appearance of cellulite has been approved for use in the US.
The “Synchronous Ultrasound Parallel Beam” (Superb) technology heats the skin at the right depth to reduce cellulite on the lateral and posterior parts of the upper thighs and buttocks.
Sofwave Medical, the Israeli company behind the technology has previously used it to reduce facial wrinkles. It says a single treatment works in 30 to 45 minutes with no post-treatment discomfort.
A total of 68 women received two treatments, two to four weeks apart. Independent reviewers assessed clinical photographs from before the treatment and three months afterwards, and 89 per cent of them correctly identified which were the post-treatment images of the patients.
“We are pleased to receive FDA clearance to use the company’s proprietary Superb technology to improve the appearance of cellulite in the short term,” said Dr. Shimon Eckhouse, Chairman and Co-Founder.
“Non-invasive treatment of cellulite is one of the most desired body treatments in medical aesthetics because of the high prevalence of cellulite in women of all ages and the lack of effective and safe solutions with no patient down-time.
“Sofwave has shown once again that its investment in the development of the Superb technology to treat highly prevalent aesthetic indications bears significant fruit and will support the continued rapid growth of the company.
“Our disruptive Superb technology was designed to be efficient and easy to use, and the company invests and plans to continue investing in bringing innovative solutions to the growing aesthetic technology market generating great ROI (return on investment) to our physician customers. “